1. Home
  2. CREX vs INMB Comparison

CREX vs INMB Comparison

Compare CREX & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Creative Realities Inc.

CREX

Creative Realities Inc.

HOLD

Current Price

$3.21

Market Cap

43.3M

Sector

Technology

ML Signal

HOLD

Logo INmune Bio Inc.

INMB

INmune Bio Inc.

HOLD

Current Price

$2.05

Market Cap

39.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CREX
INMB
Founded
N/A
2015
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.3M
39.6M
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
CREX
INMB
Price
$3.21
$2.05
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$5.40
AVG Volume (30 Days)
44.2K
1.1M
Earning Date
04-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
2.86
11.85
EPS
N/A
N/A
Revenue
$18,437,000.00
$50,000.00
Revenue This Year
$81.98
N/A
Revenue Next Year
$14.82
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.61
257.14
52 Week Low
$2.19
$1.09
52 Week High
$4.42
$3.24

Technical Indicators

Market Signals
Indicator
CREX
INMB
Relative Strength Index (RSI) 32.11 71.66
Support Level $3.05 $1.21
Resistance Level $3.86 $2.30
Average True Range (ATR) 0.32 0.17
MACD -0.10 0.04
Stochastic Oscillator 1.69 82.78

Price Performance

Historical Comparison
CREX
INMB

About CREX Creative Realities Inc.

Creative Realities Inc, along with its subsidiaries, is engaged in providing digital marketing technology & solutions to world-wide retail companies, luxury and other individual retail brands, advertising networks, outdoor clients, enterprises, and other organizations. The company operates in one reportable segment, marketing technology solutions. It offers solutions related to digital merchandising systems, omnichannel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and high-end audio-visual networks, along with marketing technologies such as mobile, social media, point-of-sale transactions, beaconing, and web-based media. Geographically, the company generates maximum revenue from the United States, and the rest from Canada.

About INMB INmune Bio Inc.

INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.

Share on Social Networks: